An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.
Related Posts
Some students are choosing affordable safety schools over dream colleges after botched FAFSA rollout
Bricelyn Harrelson didn’t plan to spend six months
Bird Flu Virus Is in One in Five U.S. Milk Samples
Fragments of the bird flu virus have been f